NexGel Completes AquaMed Acquisition
Ticker: NXGLW · Form: 8-K · Filed: May 20, 2024 · CIK: 1468929
| Field | Detail |
|---|---|
| Company | Nexgel, Inc. (NXGLW) |
| Form Type | 8-K |
| Filed Date | May 20, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $400,000, $200,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, definitive-agreement, equity-sale
Related Tickers: NXGL
TL;DR
NexGel just bought AquaMed, closing a deal on May 15th. Big move for them.
AI Summary
NexGel, Inc. announced on May 15, 2024, the completion of its acquisition of AquaMed Technologies, Inc. The company also reported on the entry into a material definitive agreement and unregistered sales of equity securities. NexGel, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This acquisition signifies a significant step in NexGel's growth strategy, potentially expanding its market presence and product offerings in the medical device sector.
Risk Assessment
Risk Level: medium — The filing indicates unregistered sales of equity securities, which can sometimes signal financial strain or dilution concerns for existing shareholders.
Key Players & Entities
- NexGel, Inc. (company) — Registrant
- AquaMed Technologies, Inc. (company) — Acquired Company
- May 15, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What was the nature of the material definitive agreement entered into by NexGel, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What was the purpose of the unregistered sales of equity securities by NexGel, Inc.?
The filing mentions unregistered sales of equity securities, but the specific reasons or terms of these sales are not detailed in the provided text.
When did NexGel, Inc. officially change its name from AquaMed Technologies, Inc.?
The provided text states that the former company name was AquaMed Technologies, Inc. and the date of name change was July 23, 2009, however, NexGel, Inc. is the current registrant and AquaMed Technologies, Inc. is the acquired company.
What is NexGel, Inc.'s Standard Industrial Classification code?
NexGel, Inc.'s Standard Industrial Classification code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What is the business address of NexGel, Inc.?
The business address of NexGel, Inc. is 2150 Cabot Blvd West, Suite B, Langhorne, PA 19047.
Filing Stats: 1,245 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2024-05-20 06:15:32
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 NXGL The Nasdaq Capital Market LLC
- $400,000 — mpany paid the Seller a cash payment of $400,000 (the " Initial Cash Payment") and will
- $200,000 — thin 5 trading days of the Closing Date $200,000 in shares of the Company's common stock
Filing Documents
- form8-k.htm (8-K) — 53KB
- ex10-1.htm (EX-10.1) — 189KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-020524.txt ( ) — 518KB
- nxgl-20240515.xsd (EX-101.SCH) — 4KB
- nxgl-20240515_def.xml (EX-101.DEF) — 26KB
- nxgl-20240515_lab.xml (EX-101.LAB) — 36KB
- nxgl-20240515_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
Financial statements of business acquired
Financial statements of business acquired. (b) Pro forma financial information. No financial statements and/or pro forma financial information will be required to be filed with the Securities and Exchange Commission relating to the acquisition of the Business. (d) Exhibits 10.1 Asset Purchase Agreement dated May 15, 2024 between NexGel, Inc. and Semmens Online Pty Ltd as Trustee for Semmens Business Trust (schedules and exhibits identified in the Purchase Agreement have been omitted pursuant to Item 601b.2 of Regulation S-K). 99.1 Press release issued by NexGel, Inc. on May 16, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 20, 2024 NEXGEL, INC . By: /s/ Adam Levy Adam Levy Chief Executive Officer